Meet Chef Sara Tso

Hi, I’m Sara Tso, owner and baker for Matchbox Kitchen. I make special occasion cakes and I focus on using organic and locally sourced ingredients. With Visian ICL, I can now literally just roll out of bed and go straight to the farmers market.

Sara Masthead Desktop

What led me to Visian ICL

I started wearing glasses when I was in fifth grade and every year it would just get worse. I thought... my mom wears glasses, my dad wears glasses, my brother wears glasses, [I thought] I’m just going to wear glasses forever.

Visian ICL is an implantable lens that goes in your eye. Nothing is taken away, it’s just something added.

Sara poster

ā€œI would never be able to just wake up and go, and now I can literally just roll out of bed and go straight to the farmers market."

I make special occasion cakes and I focus on using organic and locally sourced ingredients. Having a business so reliant on fresh produce... I knew I would have to be one of the first people to get to the farmers market so I could get the best pick.

I just like how fresh everything is. It’s directly from the farmer. I get to meet who is growing what I’m using and I can learn more about their growing practices.

Sara Tso has EVO ICL lenses and is sponsored by STAAR Surgical.

Sara Questions Desktop

Questions with Sara

What do you do for a living?

I have a baking company named Matchbox Kitchen. I make special occasion cakes and I focus on using organic and locally sourced ingredients.

How long have you had problems with your vision?

I started wearing glasses when I was in 5th grade. My mom wears glasses, my dad wears glasses, my brother wears glasses, I thought I’m just going to wear glasses forever.

What’s your biggest pain point about contacts or glasses?

It became just a chore to put on my contacts and really just prepare myself for the day. I was never able to just wake up and go.

What about Visian ICL helped make your decision?

Visian ICL is an implantable lens that goes in your eye. Nothing is taken away, it’s just something added. What I really appreciate about Visian ICL is that the implantable lens is natural and biocompatible with my body. It’s something that I can trust and is safe for me.

Important Safety Information for EVO/EVO+ ICL

The EVO/EVO+ ICL is designed for the correction/reduction of up to -20 diopters (D) of nearsightedness with up to 6 D of astigmatism for patients who are 21 to 60 years of age and for patients 21 years of age or older who have been treated with an intraocular lens. Implantation of the EVO/EVO+ ICL is a surgical procedure, and as such, carries potentially serious risks. The following represent potential complications/adverse events: additional surgeries, cataract formation, transient or persistent loss of best corrected vision, raised pressure inside the eye, loss of cells on the innermost surface of the cornea, conjunctival irritation, corneal swelling, conjunctival irritation, endophthalmitis (total eye infection), significant glare and/or halos around lights, hyphema (blood in the eye), hypopyon (pus in the eye), eye infection, EVO/EVO+ ICL dislocation, macular edema, non-reactive pupil, pupillary block glaucoma, severe inflammation of the eye, iritis, uveitis, vitreous loss and corneal transplant. Before considering EVO/EVO+ ICL surgery you should have a complete eye examination and talk with your eye care professional about the EVO/EVO+ ICL procedure, especially the potential benefits, risks, and complications. You should discuss the time needed for healing after surgery.

References

References

1. Packer M. The Implantable Collamer Lens with a central port: review of the literature. Clin Ophthalmol. 2018;12:2427-2438.

2. Martínez-Plaza E, López-Miguel A, López-de la Rosa A, et al. Effect of the EVO+ Visian Phakic Implantable Collamer Lens on Visual Performance and Quality of Vision and Life, Am J Ophthalmol 2021;226:117-125.

3. Packer M. Evaluation of the EVO/EVO+ Sphere and Toric Visian ICL: Six month results from the United States Food and Drug Administration clinical trial. Clin Ophthalmol. 2022;16:1541-53.

4. Parkhurst GD. A prospective comparison of phakic collamer lenses and wavefront-optimized laser-assisted in situ keratomileusis for correction of myopia. Clin Ophthalmol. 2016;10:1209-1215.

5. Zhang H, Deng Y, Ma K, Yin H, Tang J. Analysis on the changes of objective indicators of dry eye after implantable collamer lens (ICL) implantation surgery. Graefes Arch Clin Exp Ophthalmol. 2024 Jul; 262(7):2321-2328.

6. Shoja, MR. Besharati, MR. Dry eye after LASIK for myopia: Incidence and risk factors. Eur J of Ophthalmol. 2007; 17(1): pp. 1-6.

7. Lee, Jae Bum et al. Comparison of tear secretion and tear film instability after photorefractive keratectomy and laser in situ keratomileusis. J Cataract Refract Surg., Volume 26 , Issue 9 , 1326 - 1331.

8. Parkhurst, G. Psolka, M. Kezirian, G. Phakic intraocular lens implantantion in United States military warfighters: A retrospective analysis of early clinical outcomes of the Visian ICL. J Refract Surg. 2011;27(7):473-481.